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Abstract
Background: Gastroparesis has a number of etiologies. The main ones are secondary to a
complication from diabetes mellitus, related to post vagotomy or post gastric surgical resections,
or idiopathic when the etiology is unclear. Gastroparesis secondary to a demyelinating disease of
the brain is unusual.
Case presentation: A 22-year-old woman was referred for acute onset of intractable nausea and
vomiting. She also had cerebellar deficits, dysphagia and paresthesias. Magnetic resonance imaging
(MRI) of the brain revealed an isolated area of demyelination in the medullary region. Another 24-
year-old woman had a similar presentation with right hemiplegia and MRI of the brain revealed a
distal medullary region. Both these patients had an abnormal gastric emptying test. Gastroparesis
and neurological deficits improved with intravenous corticosteroids. While the former patient has
had no further recurrences, the latter patient developed multiple sclerosis within three months of
presentation.
Conclusion: A demyelinating disease is a rare cause gastropareis, but should be suspected when
symptoms of gastroparesis are associated with neurological deficits. MRI might help in the diagnosis
and intravenous coriticosteroids can address the underlying disease process and improve gastric
emptying, especially when used early during the course of the disease.
Background
Gastroparesis is a condition characterized by evidence of
gastric retention in the absence of any mechanical
obstruction. Symptoms usually include nausea, vomiting,
post prandial fullness, and abdominal pain [1]. Diabetes
Mellitus is the commonest cause of gastroparesis, other
etiologies include idiopathic, and post surgical usually
secondary to a vagotomy [2]. A primary neurological basis
for gastroparesis is unusual. We present a series of two




A 22-year old woman was seen in the emergency depart-
ment with acute onset of intractable nausea and vomiting.
Nausea and vomiting were predominantly post-prandial
and seemed to respond partially to metoclopramide. Over
the next few weeks she also developed dysphagia, blurry
vision, paresthesias involving her lower and upper
extremities, and problems with balance. Physical exam
was significant for nystagmus on lateral gaze, quadripare-
sis, absent deep tendon reflexes in all four extremities, a
negative plantar reflex, and a positive finger-nose test. No
history of vertigo was obtained, cranial nerves were intact,
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course was complicated by renal failure secondary to
dehydration, which subsequently resolved. She had a jeju-
nal feeding tube (J-tube) placed for nutritional support.
Laboratory analysis was significant for elevated creatinine
initially which later resolved. Cerebrospinal fluid (CSF)
analysis was remarkable only for oligoclonal bands
(OB's). Magnetic resonance imaging (MRI) of the head
and the cervical spine revealed a focal area of demyelina-
tion near the cervico-medullary junction (Figure 1). There
was an interval increase in the size of this lesion over the
next few weeks. A scintigraphic four-hour gastric emptying
test (GET) was performed. The patient consumed a low fat
(2%) Eggbeater meal (255 kcal) labeled with 1mCi99Tc
sulfur colloid and 170 cc of water. 46% of the meal was
retained at the end of 4 hours (Normal: < 10% retention
at the end of 4 hours) Upper endoscopy (EGD) was nega-
tive for gastric outlet obstruction. As the patient's symp-
toms were worsening intravenous methylprednisolone at
a dose of 1 gram daily for 2 weeks was instituted followed
by a prednisone taper resulted in improvement in nausea,
vomiting, and other neurological deficits. The total dura-
tion of corticosteroid use was for two months. A repeat
MRI after treatment showed resolution of the lesion in the
medulla (Figure 2). A follow up GET was normal with 8 %
retention of the radionuclide meal at the end of four
hours. After the patient's oral intake improved and she
could keep up with her nutritional requirements, the J-
tube was discontinued after 6 months of initial presenta-
tion. At the 1-year follow up visit the patient had no neu-
rological or gastrointestinal (GI) complaints, was off all
medications, actively employed, and functioning with no
complaints.
Case 2
A 24 year old woman was referred to our hospital with
symptoms of persistent post-prandial nausea, vomiting,
new onset right sided weakness, and paresthesias. Symp-
toms started 2 weeks prior to presentation. Physical exam
was positive for facial nerve palsy on the right side,
reduced motor strength in the right upper and lower
extremities, absent deep tendon reflexes on the right side,
plantar- flexor response, abnormal finger-nose test, and a
broad-based unsteady gait. Fundoscopic examination was
normal. EGD was negative. GET performed by the previ-
ously described technique was conclusive for gastropare-
sis with 83% retention of food at the end of four hours.
MRI revealed demylenating lesions in distal medulla,
extending caudally through the cervico-medullary junc-
tion. The patient was started on 1 gram of methylpred-
nisolone daily intravenously for 10 days, followed by a
tapering dose of oral prednisone and this resulted in a
gradual improvement of her nausea, vomiting, and neuro-
logical symptoms. GET repeated after 10 days showed
remarkable improvement with only 13% retention of
food at the end of 4 hours. Three months later, she devel-
oped additional neurological symptoms and was diag-
nosed with multiple sclerosis (MS). No recurrence of GI
symptoms was reported.
Resolution of the lesion after treatment with corticosteroidsFigure 2
Resolution of the lesion after treatment with corticosteroids.
Demyelinating lesion of the brainstem at presentationFigur  1
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The patients presented above had an acute onset of neuro-
logical deficits and gastroparesis associated with a lesion
in the medulla. Treatment with corticosteroids led to res-
olution of gastroparesis. Simultaneous improvement of
symptoms of gastroparesis and size of the brain lesion
support the primary neurological etiology for gastropare-
sis. The demyelinating disease could have affected the
vagal nerve nuclei in these patients, which explains their
GI complaints. Though, corticosteroids can help nausea
and vomiting especially when associated with chemother-
apy, they do not improve gastric emptying [3,4]. The role
for corticosteroids in MS is to treat of acute symptomatic
relapses of MS [5,6]. Treatment with corticosteroids in
other demyelinating conditions such as acute optic neuri-
tis has also been shown to reduce the onset of MS [7]. The
same might apply in this particular scenario also. Proki-
netic medications, such as metoclopramide and domperi-
done do not affect the course of the disease in MS, unless
patients have symptoms of nausea and vomiting.
An intact vagal nerve is essential for gastric emptying. The
vagus nerve affects gastric motility by coordinating the
appearance of the gastric migrating motor complex
(MMC) in the fasting state and help in the generation of
the digestive motor pattern after eating a meal, which
leads to gastric emptying. Vagal blockade has been associ-
ated with impairment of MMC and delayed gastric empty-
ing of a solid meal resulting in symptoms of nausea,
vomiting, postprandial fullness, abdominal pain, and
weight loss [8]. Another contributing factor for the
delayed gastric emptying observed in our patients might
be the unopposed adrenergic drive secondary to demyeli-
nation of the vagal nerve nuclei [9]. A further possible
explanation for the gastroparesis could be a disturbance to
the vestibular nuclei in the brain stem region, which may
lead to a delay in gastric emptying [10].
Slow gastric emptying is an infrequent complication of
MS occurring many years after disease onset [11-14]. This
is in contrast to the patients presented above, where they
were healthy before manifesting symptoms of gastropare-
sis and developing a demyelinating lesion in the brain-
stem. A similar case report was found in literature where
the disease course was very similar to the patients
described above [15]. One patient (Case 1) had OB's in
her CSF has been free of any recurrences to date. She fit the
profile for clinically isolated demyelinating disease of the
brain stem. However OB's in the CSF predict the develop-
ment of MS in the future [16].
Conclusion
Gastroparesis with neurological symptoms might indicate
a demyelinating disease of the central nervous system and
predict development of MS in the future. MRI of the brain
is recommended in patients with neurological deficits and
symptoms of delayed gastric emptying. Administration of
corticosteroids early in the course of the disease seems to
resolve the demyelinating process, thus improving gas-
troparetic symptoms and normalizing gastric emptying
test results.
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